RNS Number : 9478Y
Xenetic Biosciences PLC
08 March 2012
Xenetic Biosciences plc
Xenetic Biosciences plc ("Xenetic" or "the Company") announces that application has been made to AIM, a market of the London Stock Exchange plc, for the admission of 61,046 ordinary shares of 0.5p each (the "New Ordinary Shares").
The New Ordinary Shares are being admitted pursuant to the exercise of options under the Company's Unapproved Share Option Plan.
It is expected that dealings in the New Ordinary Shares, which will rank pari passu in all respects with the existing issued share capital of the Company, will commence on 9 March 2012.
Following admission the Company will have 407,875,428 ordinary shares in issue.
This information is provided by RNS
The company news service from the London Stock Exchange